Table 1.

Patient characteristics.

	Phenytoin	No phenytoin
	(N = 43)	(N = 96)
Male sex	21 (49%)	54 (56%)
Age (years) mean ± SD	47 ± 15.9	50 ± 13.3
Diagnosis
AMLa	29	57
CMLb	1	2
Myelofibrosis	1	20
ALLc	6	8
Other	6	9
Stemcell source
Autologous	10	51
Allogeneic	33	45
Busulfan conditioning regime
0.8 mg/kg (IV)	0	89
1 mg/kg (oral)	43	7
Mortality	20 (46%)	33 (34%)

^aAML, Acute myeloid leukemia.

^bCML, Chronic myeloid leukemia.

^cALL, Acute lymphoid leukemia.